Peer Review History
Original SubmissionJuly 10, 2019 |
---|
PONE-D-19-19438 Overexpression of MdCPK1a gene, a calcium dependent protein kinase in apple,increase tobacco cold tolerance via scavenging ROS accumulation PLOS ONE Dear Dr. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We'd like to ask you to carefully read the comments of the reviewers, and revise the manuscript. We would appreciate receiving your revised manuscript by Oct 26 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Hidenori Sassa Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. For reproducibility reasons we would recommend that you amend your methods section to include the source and/or deposition numbers of all the plants and seeds used in your study. We would also recommend providing some minimal details regarding the protocols references in section "Physiological measurements and histochemical staining protocol details" to allow researchers that may not have access to these references to reproduce your findings. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 4. Thank you for stating in your Funding Statement: [This work was supported by the National Natural Science Foundation of China (31872076, 31560551).]. * Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. * Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Authors identified CPK1a from apple and characterized it. In addition, this research revealed that MdCPK1a might play important roles in the acclimation of plants to cold stress as well as salt and heat stress via activation of ROS scavenging systems. It might be important research leading to the elucidation of the roles of CDPK in crops, however, the points below should be addressed for the publication in this journal. Authors indicated the nuclear and cytosolic localization of MdCPK1a by GFP fusion protein. But, nuclear localization should be confirmed by DAPI staining. In the picture taken from the top (“a” on the left panel) in Fig.3, A2 plants seem to be much larger than WT plants. However, shoot and root dry weight of A2 are comparable with that of WT plants. This discrepancy between picture and graph should be explained. In this study, the results presented in Figure 7 are essential to support the main conclusions. Authors therefore should quantify amount of ROS with more accurate way. Especially, the ways to quantify H2O2 by fluorescent dye or kit have been established. Although the stress response phenotypes of the transgenic plants are shown in this study, the effects of MdCPK1a expression on growth of transgenic plants under non-stressed conditions are not clearly shown. The growth phenotypes of transgenic plants need to be analyzed and presented. Reviewer #2: The manuscript by Dong et al describes the role of a calcium-dependent protein kinase from apple, MdCPK1a, in abiotic stress tolerance, using ectopic overexpression in tobacco plants. The transgenic lines appear more tolerant to salt and cold while they behave like wild-type under drought stress. The authors further studied the cold responses to link CDPK-mediated cold tolerance and ROS detoxification, by measuring ROS level, activity of detoxifying enzymes and gene expression. However, some results are not consistent. Major comment: 1. The 3 transgenic lines should behave similarly to link the phenotype to the expression of MdCPK1a, or at least follow the overexpression level. Yet, it is often not the case. For heat stress, the higher MdCPK1a is expressed, the lower the tolerance is induced (Fig 5) and the authors claim in the abstract l.16 that “Ectopic expression of MdCPK1a in Nicotiana benthamiana increased its salt, heat and cold resistance” while in the discussion, they state l.303-304: “ectopic expression of MdCPK1a improved tobacco cold tolerance and also exhibit slightly increased salt tolerance, but no obvious improvement of heat and drought tolerance”. For cold, lines A4 and A36 already appear much bigger than WT in control conditions when grown on plates (Fig 6a), which questions whether the increased tolerance to cold is specific or just a consequence of initial bigger size. Moreover, the analyzed molecular parameters, i.e. enzyme activity and gene expression, are not consistent in the 3 transgenic lines, which makes it difficult to link those responses to MdCPK1a overexpression. 2. In Fig 2, the fluorescent signal of MdCPK1a-GFP being very weak, it is difficult to conclude that MdCPK1a localizes to plasma membrane and not cytosol. The authors should improve the quality of the pictures and check by western-blot that the signal corresponds to the fusion protein and not to GFP alone. 3. The literature is not always relevant. For example, l. 33 ref 52 is more relevant than ref 1. L. 45, ref 6 and 10 are not relevant here. L. 263, ref 51 doesn’t deal with AtCPK1. Instead, the authors should cite ref 48 and Gao et al Plos Pathogen 2013 vol 9: e1003127. And Ref 52 is not relevant there. L. 298, the authors should include OsCPK24 (Liu et al 2018 Journal of Integrative Plant Biology vol 2 p.173-188). L. 326, ref 74 is not relevant. Instead, the authors should cite Boudsocq et al Nature 2010 vol 464 p. 418-22; Dubiella et al, PNAS 2013 vol 110 p. 8744-8749; Gao et al Plos Pathogen 2013; Kadota et al Molecular Cell 2014 vol 54, p. 43-55. Minor comments: 1. In Fig 3a, on the left panel, line A2 seems to be as tolerant as lines A4 and A36, which is different in the right panel. Moreover, the 2 panels are not well explained in the legend. The statistics are missing in fig 3b. 2. In Fig 7, the ROS should be quantified. 3. the stress protocols are not similar in methods and results. They should be clarified. 4. the English should be improved. 5. Figure legends are inverted in Fig 6 between panels c, d, e and f l. 403-407; sup fig S1 and S2 are inverted l.427, 437. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-19-19438R1 Overexpression of MdCPK1a gene, a calcium dependent protein kinase in apple,increased tobacco cold tolerance via scavenging ROS accumulation PLOS ONE Dear Prof. Wang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please carefully read the reviewers' comments and revise the manuscript. Especially, the Reviewer 2's comments are critical. We would appreciate receiving your revised manuscript by Jan 26 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Hidenori Sassa Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Basically, authors properly answered the comments by explaining the detail. However, I found another point to be modified. Fig.4 might be important pictures that also show difference in growth even under normal condition. Scale bars should be indicated to further provide information of plant size. Reviewer #2: The authors answered part of the initial comments but some points still need clarification. Major comments: 1. The part on heat tolerance is confusing since the authors conclude l. 434-436 that “ectopic expression of MdCPK1a exhibit…no obvious improvement of heat and drought tolerance” while in the results, they state l.310-311 “the survival rates of…A36 (24%) and A2 (98%) were remarkably higher than WT”. Indeed, the thermotolerance is inversely correlated with MdCPK1 expression level in the transgenics, which makes it difficult to conclude without any additional investigation. Thus, the whole part on heat stress tolerance should be deleted from this manuscript. 2. The picture of MdCPK1 localization has been more contrasted. However, the membrane localization is still not demonstrated. Indeed, some cytoplasmic strands are visible and MdCPK1 could be located in cytosol and/or plasma membrane. This experiment is important to correlate with the acylation prediction of MdCPK1. Either the authors balance their statement, or they provide additional data such as co-localization with known plasma membrane protein, or western-blot of proteins extracted in the presence/absence of triton X100 which will extract total proteins including the membrane ones (presence) or only soluble ones (absence). Moreover, a western-blot will additionally prove that the fluorescence observed is due to MdCPK1-GFP fusion and not GFP alone. Finally, “plasma membrane” should be deleted l.265-266 since free GFP doesn’t go to membrane. It only diffuses to cytosol and nucleus. Minor comments: 1. In Fig3, the discrepancy between pictures (a, left panel) and graphs (b, left panel) is surprising. Maybe measuring fresh weight would have been more relevant here. Nevertheless, the authors could comment on that: it suggests that under salt stress, MdCPK1 transgenics retain water better than WT. 2. In Fig7, the authors added quantification of the ROS staining. The corresponding legend is missing l.358-362, the panels c and d should be cited in the results l.352, and the way they quantified the staining should be explained in the methods. 3. In the discussion l.447-448, the authors state that “the aerial part of WT plants is little higher than that of transgenics under normal conditions”. However, the picture in Fig4 shows that WT plants are actually smaller than the transgenics in control conditions. This should be corrected. 4. The stress protocols are still different in methods and figures. In results, salt stress (l.285) and drought (l.303) are performed for 25d on 4-week-old plants while in the methods, 4-week-old plants are further grown for 14d before applying stress, ie 6-week-old before stress (l.169-170). Also correct accordingly if needed the legend l.305-307. 5. L.86, Ralstonia solanac should be Ralstonia solanacearum. L.402, predicated should be predicted. 6. English still needs some improvement, especially l.89-91, l.113-115, l.178-180. 7. L.251, the sentence should be rephrased by “the selected CDPK proteins were clustered into three subgroups” because the authors just didn’t include CDPKs from subgroup IV. L.252, ZmCDPK1 should be “ZmCPK1”. 8. In FigS2, the qRT-PCR (panel e) is missing. 9. Fig6 has been reorganized but the labels are now wrong: a and b are inverted, c and d, and e and f, as well. Moreover, the genotype labelling is missing in panel b (which should be “a” with MS and MS+4°C). 10. L.375-378, the sentence should be modified because NtSPS and NtLEA5 are already strongly induced in MdCPK1 transgenics in normal conditions. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Overexpression of MdCPK1a gene, a calcium dependent protein kinase in apple,increased tobacco cold tolerance via scavenging ROS accumulation PONE-D-19-19438R2 Dear Dr. Wang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hidenori Sassa Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I think authors properly answered the comments from reviewers. Indeed, the manuscript was much improved after the revisions. For me, this manuscript is currently sufficient for the publication in this journal. Reviewer #2: The authors answered almost to all my comments. There are just few minor editing points left: 1. English still needs improvement. L. 87-88 could be “Conversely, some CDPKs are negative regulators of stress responses because transgenic plants overexpressing them are more sensitive to abiotic/biotic stresses.” L.352-354 could be “To know whether MdCPK1a regulates ROS levels in cold response, we compared the ROS levels in the overexpressing tobacco lines and WT plants after suffering cold stress.” 2. l.191, “3 ml” has been replaced by “equal volume”. But this would correspond to 1 ml, and not 3 ml. Please correct or confirm the good value. 3. l.259, and l.399, ZmCDPK1 should be ZmCPK1. 4. L.469, ref 48 should be ref 49. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
Formally Accepted |
PONE-D-19-19438R2 Overexpression of MdCPK1a gene, a calcium dependent protein kinase in apple,increase tobacco cold tolerance via scavenging ROS accumulation Dear Dr. Wang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hidenori Sassa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .